Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartzet al
Will Dixon, Alan SilmanVolume:
8
Language:
english
DOI:
10.1186/ar2026
Date:
October, 2006
File:
PDF, 42 KB
english, 2006